File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Management of osteoporosis in Hong Kong.

TitleManagement of osteoporosis in Hong Kong.
Authors
Issue Date2004
Citation
Clinical Calcium, 2004, v. 14 n. 9, p. 108-111 How to Cite?
AbstractOsteoporosis is among the top 3 medical conditions that are associated with greatest morbidity and reduction of quality of life of Hong Kong elderly subjects. The genetic and environmental risk factors for osteoporosis in southern Chinese as well as the current approach towards managing this growing health problem in Hong Kong are presented.
Persistent Identifierhttp://hdl.handle.net/10722/162820
ISSN
2015 SCImago Journal Rankings: 0.150

 

DC FieldValueLanguage
dc.contributor.authorKung, AWen_US
dc.date.accessioned2012-09-05T05:23:56Z-
dc.date.available2012-09-05T05:23:56Z-
dc.date.issued2004en_US
dc.identifier.citationClinical Calcium, 2004, v. 14 n. 9, p. 108-111en_US
dc.identifier.issn0917-5857en_US
dc.identifier.urihttp://hdl.handle.net/10722/162820-
dc.description.abstractOsteoporosis is among the top 3 medical conditions that are associated with greatest morbidity and reduction of quality of life of Hong Kong elderly subjects. The genetic and environmental risk factors for osteoporosis in southern Chinese as well as the current approach towards managing this growing health problem in Hong Kong are presented.en_US
dc.languageengen_US
dc.relation.ispartofClinical calciumen_US
dc.subject.meshBone Densityen_US
dc.subject.meshCalcium, Dietary - Administration & Dosageen_US
dc.subject.meshCost-Benefit Analysisen_US
dc.subject.meshEstrogen Replacement Therapyen_US
dc.subject.meshHealth Educationen_US
dc.subject.meshHong Kong - Epidemiologyen_US
dc.subject.meshHumansen_US
dc.subject.meshLife Styleen_US
dc.subject.meshOsteoporosis - Economics - Epidemiology - Etiology - Prevention & Controlen_US
dc.subject.meshParathyroid Hormoneen_US
dc.subject.meshPrimary Preventionen_US
dc.subject.meshQuality Of Lifeen_US
dc.subject.meshRaloxifene - Therapeutic Useen_US
dc.subject.meshRisk Factorsen_US
dc.subject.meshSelective Estrogen Receptor Modulators - Therapeutic Useen_US
dc.subject.meshVitamin D - Therapeutic Useen_US
dc.titleManagement of osteoporosis in Hong Kong.en_US
dc.typeArticleen_US
dc.identifier.emailKung, AW:awckung@hku.hken_US
dc.identifier.authorityKung, AW=rp00368en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.pmid15577121-
dc.identifier.scopuseid_2-s2.0-16644384050en_US
dc.identifier.hkuros97924-
dc.identifier.volume14en_US
dc.identifier.issue9en_US
dc.identifier.spage108en_US
dc.identifier.epage111en_US
dc.publisher.placeJapanen_US
dc.identifier.scopusauthoridKung, AW=7102322339en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats